The S&P/ASX 200 Index (ASX: XJO) contains plenty of shares I would be comfortable owning for years.

For a 10-year investment, I would look for companies with strong positions today and plenty of room to keep growing.

With that said, these three ASX 200 shares would be high on my list.

Xero Ltd (ASX: XRO)

Xero is already a major player in cloud accounting, but I still think the business has a long way to run.

Its software helps small businesses manage areas such as invoicing, payroll, payments, reporting, and everyday financial administration.

Once a business has moved its accounts onto Xero and connected its accountant and other applications, the software can become deeply embedded in how it operates.

That can make its platform very sticky and help Xero retain customers while also giving it opportunities to offer them more services over time.

I particularly like the size of the market still available. Xero had around 4.9 million customers in FY26, compared with a global addressable market of roughly 100 million small businesses.

Payments, payroll, artificial intelligence (AI), and its expansion into areas such as accounts payable could all help Xero become a larger part of how those businesses manage their finances.

Over the next decade, I think both customer growth and deeper use of the platform could drive the company much higher.

ResMed Inc. (ASX: RMD)

ResMed would give me exposure to a completely different long-term opportunity.

The healthcare company develops devices, masks, and software for sleep apnoea and respiratory care.

ResMed has been growing for decades but is still only scratching the surface of its overall opportunity. More than one billion people globally are estimated to have sleep apnoea, while diagnosis and treatment rates remain relatively low. That leaves ResMed with a huge population still to reach.

Over a decade, I think the combination of an underserved healthcare need, recurring sales, and continued product development gives ResMed plenty of room to expand.

Goodman Group (ASX: GMG)

Goodman would be my third ASX 200 share pick.

The property group owns and develops industrial assets in major cities around the world, including warehouses, logistics facilities, and increasingly data centres.

I like the locations Goodman has accumulated. Large sites with access to power, transport links, and major population centres can become increasingly difficult to secure as cities grow.

That puts Goodman in a strong position as demand increases for logistics facilities and digital infrastructure.

Data centres could become particularly important as cloud computing and artificial intelligence require more computing capacity and electricity.

Projects of this scale take time and capital to develop, but Goodman already has the land, relationships, and development expertise needed to participate.

Foolish takeaway

10 years gives these businesses plenty of time to build on the positions they already have.

Xero can reach more small businesses, ResMed can treat more patients, and Goodman can continue developing scarce infrastructure in major global markets.

I think those opportunities make all three ASX 200 shares worth considering for a long-term portfolio.

The post 3 ASX 200 shares I’d buy and hold for a decade appeared first on The Motley Fool Australia.

More reading

• How much passive income could I make by investing $500 a month in ASX shares?
• 7 ASX 200 shares with reaffirmed buy ratings this week
• Forget Xero shares! Broker tips this top ASX tech stock for 24% gains
• 5 ASX shares I’d recommend to beginners
• CSL, Resmed, and more. See which ASX health stocks RBC Capital Markets has upgraded

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group, ResMed, and Xero. The Motley Fool Australia has positions in and has recommended ResMed and Xero. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Commonwealth Bank of Australia (ASX: CBA) shares are paying more dividends than ever before.

And with shares in the S&P/ASX 200 Index (ASX: XJO) bank stock recently trading for $152.75 apiece, down 15.1% from their 6 August close, is CommBank stock now a good buy for passive income?

Let’s have a look.

Should I buy CBA shares for passive income?

While we could look at the forward dividend yields for CBA, those are simply based on analysts’ current best forecasts. Or guesses, if you will.

With the future inherently uncertain, we’ll instead base our investment case on the FY 2026 dividends. Or trailing yields. Just keep in mind that future yields may be higher or lower depending on a number of company specific and macroeconomic factors.

As for FY 2026, CBA paid a fully franked interim dividend of $2.35 a share on 30 March.

When the bank released its FY 2026 results on 12 August, it reported a 7% increase in cash net profit after tax (NPAT) to $11 billion.

This saw management declare a fully franked dividend of $2.70 per share.

That brings the total FY 2026 dividends to $5.05 a share, up 4.1% from FY 2025 and representing a new all-time high passive income payout.

And at the recent CBA share price, it sees Australia’s biggest bank trading at a fully franked trailing dividend yield of 3.3%.

So, how does the dividend yield from the other big four ASX 200 bank stocks compare?

How do the other ASX 200 bank stocks stack up?

While investors buying CBA shares today will receive materially higher future dividend yields than those who bought the stock in the first weeks of August, CBA’s dividend yield still trails its three biggest rivals.

For example, at recent share prices, National Australia Bank Ltd (ASX: NAB) and ANZ Group Holdings Ltd (ASX: ANZ) shares both trade at dividend yields of 4.4%.

And Westpac Banking Corp (ASX: WBC) shares trade on a 4.5% fully franked trailing dividend yield.

What are analysts saying about CBA shares?

Despite the reliable passive income on offer, most analysts recommend steering away from CommBank stock at the moment. Many remain concerned the ASX 200 bank remains overvalued despite the past month’s share price retrace.

Earlier this week, Shaw and Partners’ James Bills issued a sell recommendation on CBA shares (courtesy of The Bull).

According to Bills:

In our view, the stock trades at a significant premium to domestic peers and on historical valuations.

While the bank maintains a high-quality franchise and strong market position, earnings growth is expected to remain modest amid competitive lending conditions and regulatory pressures.

Recent Federal government initiatives aimed at increasing housing supply and improving affordability is likely to lead to intensifying competition across the mortgage market and place pressure on lending margins.

Current valuations leave limited scope for further earnings driven upside. Investors may wish to take profits and re-deploy capital into opportunities offering stronger risk-adjusted return potential.

The post Down 15% and paying record dividends: Are CBA shares now a good buy for passive income? appeared first on The Motley Fool Australia.

More reading

• Are BHP, CBA, and CSL shares top buys?
• 7 ASX 200 shares with reaffirmed buy ratings this week
• Starting with $20,000, how to build a portfolio generating $5,000 a year in passive income
• Telstra vs NAB: Which ASX blue chip is the better buy?
• 6 ASX 200 shares boosted by brokers this week

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) has underperformed in 2026 compared to international markets. 

At the time of writing, Australia’s benchmark index is essentially flat year to date. 

But Aussie investors aren’t sitting around waiting for the tide to turn. 

Instead, they are looking towards international equities for stronger returns. 

A recent report from Betashares identified how this is playing out in the ASX ETF market. 

According to the report, international equities broke another monthly record in August at $3.8 billion in net inflows, surpassing July’s previous high of $3.56 billion. 

As a result of recent weakness in Australian equities, investors are rethinking their long-term investment plans with international equity ETFs emerging as a clear beneficiary. The category has now set a new all-time monthly record in consecutive months, while Emerging Market ETFs also saw record inflows this month.

For investors looking for global diversification with ASX ETFs, here are three that have performed well in 2026. 

Betashares Capital – Asia Technology Tigers ETF (ASX: ASIA)

One of the best performing ASX ETFs this year from Betashares has been this Asian technology-focused fund. 

Up 32% year to date, it tracks the performance of an index (before fees and expenses) comprising the 50 largest technology and online retail stocks in Asia (ex-Japan). 

The big driver has been AI and semiconductor exposure.

It essentially offers another way of playing the AI boom, through the companies manufacturing the hardware rather than primarily through the US companies selling the software/services.

Betashares MSCI Emerging Markets Complex ETF (ASX: BEMG)

Another theme in 2026 has been emerging markets.

Emerging markets generally refer to countries or regions undergoing fast economic growth. 

Usually, countries that are undergoing growth and industrialisation.

In the case of this fund from Betashares, it offers exposure to large and mid-cap stocks across 24 emerging market countries.

Almost 80% of the fund is made up by companies from Taiwan, South Korea, China, and India. 

By sector, it has a strong weighting towards tech and financials. 

In 2026, it has risen over 14%. 

Vaneck MSCI International Value (AUD Hedged) ETF (ASX: HVLU)

Another internationally focused fund that has outperformed the Australian market this year has been this fund from VanEck. 

It provides a diversified portfolio of 250 international developed market large and mid-cap companies, with high value scores as calculated by MSCI at each rebalance, with returns hedged into Australian dollars.

The value rating is based on: price to book value, price to forward earnings, and enterprise value to cash flow from operations.

It has risen by over 22% year to date. 

The post Aussie investors are pushing their chips into international ASX ETFs – Here are three great options appeared first on The Motley Fool Australia.

More reading

• Where to invest $2,500 in ASX ETFs now
• 5 ASX ETFs to buy and hold forever
• 3 very exciting ASX ETFs for investors to watch
• Why these ASX ETFs could be strong long-term picks
• 3 exciting ASX ETFs to watch

Motley Fool contributor Aaron Bell has positions in Betashares Capital – Asia Technology Tigers Etf. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.